SM3321
/ StarMab Biomed
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
July 24, 2026
Clinical Study of SM3321 With Solid Tumors
(clinicaltrials.gov)
- P1 | N=7 | Completed | Sponsor: Beijing StarMab Biomed Technology Ltd | Recruiting ➔ Completed | N=48 ➔ 7
Enrollment change • Trial completion • Oncology • Solid Tumor
December 18, 2023
Clinical Study of SM3321 With Solid Tumors
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Beijing StarMab Biomed Technology Ltd | Initiation date: Aug 2023 ➔ Dec 2023
Metastases • Trial initiation date • Breast Cancer • Oncology • Solid Tumor • CD4 • IL2
October 18, 2023
Clinical Study of SM3321 With Solid Tumors
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Beijing StarMab Biomed Technology Ltd
Metastases • New P1 trial • Breast Cancer • Oncology • Solid Tumor • CD4 • IL2
1 to 3
Of
3
Go to page
1